Glenmark Pharmaceuticals informs about press release

02 Aug 2021 Evaluate

Glenmark Pharmaceuticals has informed that it has attached media release on 2nd August 2021 titled ‘Glenmark inks agreement with Canadian biotech SaNOtize to commercialize Nitric Oxide Nasal Spray for COVID?19 treatment in India and other Asian markets’.

The above information is a part of company’s filings submitted to BSE.

Glenmark Pharma Share Price

2000.25 7.55 (0.38%)
29-Jan-2026 10:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1588.25
Dr. Reddys Lab 1199.75
Cipla 1312.75
Zydus Lifesciences 882.80
Lupin 2103.10
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×